104249-15-2 Usage
General Description
1H-Isoindole-1,3(2H)-dione, 2-[(2E)-4-bromo-2-butenyl]- is a chemical compound with the molecular formula C12H10BrNO2. It is a derivative of isoindole-1,3(2H)-dione, a cyclic molecule containing an indole and a carbonyl group. The compound contains a 2-[(2E)-4-bromo-2-butenyl] substituent, which is a butenyl group with a bromine atom at the 4th position. 1H-Isoindole-1,3(2H)-dione, 2-[(2E)-4-bromo-2-butenyl]- may have potential applications in organic synthesis, pharmaceuticals, or materials science, and its properties and reactivity would need to be further investigated to determine its potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 104249-15-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,2,4 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 104249-15:
(8*1)+(7*0)+(6*4)+(5*2)+(4*4)+(3*9)+(2*1)+(1*5)=92
92 % 10 = 2
So 104249-15-2 is a valid CAS Registry Number.
104249-15-2Relevant academic research and scientific papers
COMPOUNDS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR, INFLAMMATORY AND IMMUNE DISORDERS
-
, (2008/06/13)
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i,e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. Also disclosed is a method to treat disorders mediated by PAF and/or leukotrienes that includes administering an effective amount of one or more of the above-identified compounds or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, to a patient in need of such therapy.
